Načítá se...
The Law and Ethics of Switching from Biologic to Biosimilar in Canada
Governments and financial institutions in several jurisdictions are planning or implementing nonmedical/‘forced’ switches by cutting drug coverage for reference biologics and funding only less expensive biosimilars. Switches raise numerous ethical and legal challenges, as the drugs are framed as not...
Uloženo v:
| Vydáno v: | J Can Assoc Gastroenterol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7465550/ https://ncbi.nlm.nih.gov/pubmed/32905067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz043 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|